IM Cannabis (IMCC) Divestments (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Divestments of $3.8 million for Q2 2021, up 512.39% year-over-year from $613744.6 in Q2 2020, and up 512.39% quarter-over-quarter from $613744.6 in Q2 2020.
IM Cannabis (IMCC) Divestments (2020 - 2026) Analysis & Trends
IM Cannabis' Divestments history runs 2 years deep, the most recent figure standing at $3.8 million for Q2 2021.
- In Q2 2021, Divestments rose 512.39% year-over-year to $3.8 million; the TTM figure through Dec 2024 stood at $4.4 million (changed N/A YoY), while the FY2024 annual figure was -$252718.2, changed N/A from the prior year.
- Divestments for Q2 2021 stood at $3.8 million, up from $613744.6 in the prior quarter.
- The five-year high for Divestments was $3.8 million in Q2 2021, with the low at $613744.6 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312.83 |
| Jun 30, 2021 | 3.76 Mn |
| Jun 30, 2020 | 613,744.56 |